STOCK TITAN

Elena Plesco Joins Abacus Life (ABL) as Chief Capital Officer

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Abacus Life, Inc. (ABL) appoints Elena Plesco as Chief Capital Officer to enhance capital management and global expansion. Ms. Plesco brings extensive investing experience from KKR and J.P. Morgan, aiming to optimize financial structure and drive long-term growth for Abacus.
Positive
  • None.
Negative
  • None.

ORLANDO, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced that Elena Plesco has joined Abacus as Chief Capital Officer.

Based in New York, Ms. Plesco has over a decade of investing experience in the financial services and assets sectors. Ms. Plesco is joining Abacus from KKR, where she served as the Co-Head of Specialty Finance, within the asset-based finance business, focused on debt and equity investments in consumer and esoteric finance companies. Prior to KKR, she worked in the investment banking division of J.P. Morgan where she was involved in a variety of mergers, acquisitions, and other advisory transactions. As Chief Capital Officer for Abacus, Ms. Plesco will oversee capital management initiatives, ensuring optimization of the company's financial structure and facilitating global expansion through strategic investments.

“We’re thrilled to welcome Elena to the Abacus team as we continue to broaden our financial and business scope,” said Abacus Chief Executive Officer Jay Jackson. “Elena brings a wealth of investing and financing experience across several different asset classes, which complements our ongoing goal of further enhancing our investment management services. We are looking forward to having her help maximize returns for our shareholders.”

“I am truly energized to embark on this journey with Abacus,” added Ms. Plesco. “Having known the management team for over five years, I am impressed with what they have been able to build. I look forward to leveraging our collective expertise to drive forward the ambitious long-term growth strategy of Abacus as a global financial player.”

About Abacus

Abacus is a leading vertically integrated alternative asset manager and market maker, specializing in longevity and actuarial technology. The company is democratizing the life insurance space through three groundbreaking new channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds. Since 2004, Abacus has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $5BN in face value of policies purchased, we have helped thousands of clients maximize the value of life insurance. Abacus Life is the only public life settlement company, trading on the Nasdaq Exchange under the ticker symbol ABL.

Over the past 20 years, the company has built an institutionalized origination and portfolio management process that is supported by a 100+ person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.

www.Abacuslife.com

Forward-Looking Statements

All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus’s financial and operational outlook; Abacus’s operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus’s ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “expect,” ‎‎”intend,” “anticipate,” “goals,” “prospects,” “will,” “would,” “will continue,” “will likely result,” and similar expressions (including the negative versions of such words or expressions).

While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the ‎fact that Abacus’s loss reserves are bases on estimates and may be inadequate to cover ‎its actual losses; the failure to properly price Abacus’s insurance policies; the ‎geographic concentration of Abacus’s business; the cyclical nature of Abacus’s industry; the ‎impact of regulation on Abacus’s business; the effects of competition on Abacus’s business; the failure of ‎Abacus’s relationships with independent agencies; the failure to meet Abacus’s investment ‎objectives; the inability to raise capital on favorable terms or at all; the ‎effects of acts of terrorism; and the effectiveness of Abacus’s control environment, including the identification of control deficiencies.

These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with ‎the U.S. Securities and Exchange Commission from time to time, including the Annual ‎Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent ‎periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the ‎forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations.

Contact

Abacus Life Investor Relations
investors@abacuslife.com

Abacus Life Public Relations
press@abacuslife.com


FAQ

Who has joined Abacus Life, Inc. as Chief Capital Officer?

Elena Plesco has joined Abacus as Chief Capital Officer.

Where is Elena Plesco based?

Elena Plesco is based in New York.

What is Elena Plesco's background?

Ms. Plesco has over a decade of investing experience in financial services and assets sectors, previously working at KKR and J.P. Morgan.

What will Elena Plesco oversee as Chief Capital Officer at Abacus?

Ms. Plesco will oversee capital management initiatives, optimize the company's financial structure, and facilitate global expansion through strategic investments.

What are the expectations from Elena Plesco's role at Abacus?

Elena Plesco aims to drive forward the ambitious long-term growth strategy of Abacus as a global financial player.

Who is the CEO of Abacus Life, Inc.?

Jay Jackson is the Chief Executive Officer of Abacus.

What is Abacus Life, Inc.'s ticker symbol?

The ticker symbol for Abacus Life, Inc. is ABL.

Abacus Life, Inc.

NASDAQ:ABL

ABL Rankings

ABL Latest News

ABL Stock Data

715.46M
30.85M
61.56%
14.1%
0.99%
Insurance - Life
Investment Advice
Link
United States of America
ORLANDO